Pharmac to fully fund drug for spinal muscular atrophy
Listen now
Description
New medicines set to be publicly funded for a rare spinal disease and anaphylaxis reactions have been a cause for celebration for advocates. This morning, Pharmac announced it will fully fund a drug for spinal muscular atrophy, and Epipens. Krystal Gibbens reports. [embed] https://players.brightcove.net/6093072280001/default_default/index.html?videoId=6312951990112
More Episodes
In breaking news, the country's public hospitals have been given a target to save a total of 105 million dollars by July. Te Whatu Ora released this figure to RNZ this afternoon after a series of leaks about which health districts faced what targets.
Published 04/26/24
Asia correspondent Per Elinder Liljas speaks to Lisa Owen about the US Secretary of State's visit to China, North Korea strengthening ties with Iran and extreme temperatures hitting parts of Asia.
Published 04/26/24
News from the business sector, including a market report.
Published 04/26/24